Diana Reynoso

NeoStem Oncology LLC is focused on the production and supply of clinically relevant embryonic stem cell derived human cell populations. Founded in 2005, the mission of NeoStem Oncology is to catalyze the efficient development of human therapies based on human embryonic stem cells. The key to this goal is the production and supply of clinically relevant human cell populations using a scalable, efficient and highly reproducible process. They generate human embryonic stem cell (hESC) lines, expand them to clinically and commercially useful numbers, and differentiate them at extremely high purity using fully-defined, proprietary media and GMP processes that are FDA compliant from day one. And they do this at a fraction of the cost of conventional cell manufacturing. As a result, the company can economically supply large quantities of high purity cells for its own clinical development pipeline in specific application areas. It can also supply high purity, fully characterized, clinically relevant human cell populations to companies or other institutions for development of therapies, efficacy screening or creation of toxicity profiles for candidate drugs, or experimental research. NeoStem Oncology LLC is a privately held Delaware Corporation with headquarters and research facilities in Irvine, CA.

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.

Founded in 1999, New Mexico Angels, Inc. (NMAI) is an angel investment group located in Albuquerque, New Mexico.

CorTechs Labs, Inc. provides medical image analysis solutions. Its products include NeuroQuant, LesionQuant, PETQuanti, AutoAlign, PowerScribe Integration, and TrenWorks Analytics. The company was founded by Eric Halgren and Anders M. Dale in 1996 and is headquartered in San Diego, CA.

Oneten Capital LLC /New Mexico (Oneten Capita) is a venture capital firm founded in 2018 by Dorian Rader and Sherman McCorkle. The firm is headquartered in Albuquerque, New Mexico.

Terra Vera Corp. was founded to replace conventional pesticides that are harmful to the environment and linked to serious health issues. Terra Vera is based in Placitas, NM. The company is based on a patented technology that converts organic, inert compounds into an antimicrobial solution that is effective at inactivating many common pathogens. The solution is safe for plants, people, and pets and can be used to remediate and prevent pathogenic outbreaks that can damage or destroy crop value. The company was founded by Carlos Perea and Justin Sanchez, with Carlos Perea serving as CEO since incorporation.